HomeInsightsMarket Capitalization

Market Capitalization of Sandu Pharmaceuticals Ltd

Market Capitalization of Sandu Pharmaceuticals Ltd

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.4 K

stocks traded

Last Updated time: 05 Nov 12:12 PM

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

MARKETCAP

53.8 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 53.8 crore as of 04 Nov 24.
  • The Market Cap of Sandu Pharmaceuticals Ltd changed from ₹ 50.43 crore on March 2023 to ₹ 55.44 crore on March 2024 . This represents a CAGR of 4.85% over 2 years. .
  • The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 55.51 as of 05 Nov 12:01.

Historical Market Cap of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Sandu Pharmaceuticals Ltd

No data available

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

PRICE

55.51

-0.18 (-0.32%)

stock direction

Last updated on: Nov 05 12:01 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 202455.69
01 Nov 202456.33
31 Oct 202455.41
30 Oct 202455.22
29 Oct 202454.62
28 Oct 202454.68
25 Oct 202454.98
24 Oct 202457.73
23 Oct 202455.73
22 Oct 202456.37

BlinkX Score for Sandu Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sandu Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Sandu Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Sandu Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sandu Pharmaceuticals Ltd

No data available

* All values are in %

About Sandu Pharmaceuticals Ltd

  • Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
  • The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
  • This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
  • Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
  • Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

Sandu Pharmaceuticals Ltd News Hub

News

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 A...

Read more

06 Aug 202414:29

News

Sandu Pharmaceuticals to discuss results

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 Ju...

Read more

01 Jun 202409:25

News

Sandu Pharmaceuticals to hold board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

22 May 202412:40

News

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

21 Mar 202409:33

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Sandu Pharmaceuticals Ltd Market Cap

What is the market cap of Sandu Pharmaceuticals Ltd?

As of November 5, 2024, Sandu Pharmaceuticals Ltd has a market capitalization of ₹53.8, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Sandu Pharmaceuticals Ltd's market capitalization?

Sandu Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Sandu Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Sandu Pharmaceuticals Ltd's market capitalization change?

Sandu Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*